Jeff Garro
Stock Analyst at Stephens & Co.
(1.05)
# 3,704
Out of 4,901 analysts
50
Total ratings
32.35%
Success rate
-12.52%
Average return
Main Sectors:
Stocks Rated by Jeff Garro
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SLP Simulations Plus | Maintains: Overweight | $28 → $20 | $13.05 | +53.26% | 2 | Jul 15, 2025 | |
| TBRG TruBridge | Reiterates: Equal-Weight | $28 | $21.39 | +30.90% | 3 | Apr 10, 2025 | |
| VEEV Veeva Systems | Reiterates: Overweight | $280 | $280.39 | -0.14% | 2 | Mar 6, 2025 | |
| HCAT Health Catalyst | Maintains: Equal-Weight | $7 → $5 | $3.76 | +32.98% | 4 | Mar 6, 2025 | |
| CERT Certara | Reiterates: Overweight | $17 | $10.45 | +62.68% | 5 | Feb 27, 2025 | |
| EVH Evolent Health | Maintains: Equal-Weight | $16 → $12 | $11.39 | +5.36% | 5 | Jan 21, 2025 | |
| PRVA Privia Health Group | Reiterates: Overweight | $26 | $20.80 | +25.00% | 3 | Jan 7, 2025 | |
| DH Definitive Healthcare | Initiates: Equal-Weight | $5 | $4.02 | +24.38% | 1 | Dec 20, 2024 | |
| DOCS Doximity | Initiates: Equal-Weight | $55 | $62.01 | -11.30% | 1 | Dec 20, 2024 | |
| OPRX OptimizeRx | Initiates: Equal-Weight | $5.5 | $13.20 | -58.33% | 3 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $250 | $157.59 | +58.64% | 2 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $17 | $15.28 | +11.26% | 1 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $28 | $26.95 | +3.90% | 8 | May 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $28 | $7.90 | +254.43% | 2 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $20 | $13.55 | +47.60% | 3 | Aug 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $5 → $3.9 | $4.09 | -4.55% | 2 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4 → $3 | $2.26 | +32.74% | 3 | May 6, 2022 |
Simulations Plus
Jul 15, 2025
Maintains: Overweight
Price Target: $28 → $20
Current: $13.05
Upside: +53.26%
TruBridge
Apr 10, 2025
Reiterates: Equal-Weight
Price Target: $28
Current: $21.39
Upside: +30.90%
Veeva Systems
Mar 6, 2025
Reiterates: Overweight
Price Target: $280
Current: $280.39
Upside: -0.14%
Health Catalyst
Mar 6, 2025
Maintains: Equal-Weight
Price Target: $7 → $5
Current: $3.76
Upside: +32.98%
Certara
Feb 27, 2025
Reiterates: Overweight
Price Target: $17
Current: $10.45
Upside: +62.68%
Evolent Health
Jan 21, 2025
Maintains: Equal-Weight
Price Target: $16 → $12
Current: $11.39
Upside: +5.36%
Privia Health Group
Jan 7, 2025
Reiterates: Overweight
Price Target: $26
Current: $20.80
Upside: +25.00%
Definitive Healthcare
Dec 20, 2024
Initiates: Equal-Weight
Price Target: $5
Current: $4.02
Upside: +24.38%
Doximity
Dec 20, 2024
Initiates: Equal-Weight
Price Target: $55
Current: $62.01
Upside: -11.30%
OptimizeRx
Dec 20, 2024
Initiates: Equal-Weight
Price Target: $5.5
Current: $13.20
Upside: -58.33%
Dec 20, 2024
Initiates: Overweight
Price Target: $250
Current: $157.59
Upside: +58.64%
Dec 9, 2024
Initiates: Buy
Price Target: $17
Current: $15.28
Upside: +11.26%
May 31, 2024
Reiterates: Overweight
Price Target: $28
Current: $26.95
Upside: +3.90%
Jul 26, 2023
Reiterates: Equal-Weight
Price Target: $28
Current: $7.90
Upside: +254.43%
Aug 5, 2022
Maintains: Overweight
Price Target: $15 → $20
Current: $13.55
Upside: +47.60%
May 11, 2022
Maintains: Underweight
Price Target: $5 → $3.9
Current: $4.09
Upside: -4.55%
May 6, 2022
Maintains: Neutral
Price Target: $4 → $3
Current: $2.26
Upside: +32.74%